Literature DB >> 17986378

Neutrophils in asthma.

Ana L Macdowell1, Stephen P Peters.   

Abstract

Asthma is a complex disease with a significant inflammatory component. Multiple cell types are involved in its pathophysiology. The presence of eosinophils, the cell usually associated with allergic diseases, does not fully explain the inflammation found in asthma. Neutrophils are present in the airway of the patient with asthma in special circumstances and may represent different asthma phenotypes. Neutrophils are activated and are able to release mediators that promote and prolong asthma symptoms. Increasing evidence suggest that neutrophils may be central players with an important role in the pulmonary inflammatory process present in asthma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17986378     DOI: 10.1007/s11882-007-0071-6

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  48 in total

1.  Is the neutrophil the key effector cell in severe asthma?

Authors:  A V Kamath; I D Pavord; P R Ruparelia; E R Chilvers
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

Review 2.  Severe asthma: an overview.

Authors:  Wendy C Moore; Stephen P Peters
Journal:  J Allergy Clin Immunol       Date:  2006-03       Impact factor: 10.793

3.  Neutrophilic inflammation in childhood bronchial asthma.

Authors:  K Yasui; N Kobayashi; T Yamazaki; K Koike; K Fukushima; S Taniuchi; Y Kobayashi
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

4.  Analysis of induced sputum after air and ozone exposures in healthy subjects.

Authors:  J V Fahy; H H Wong; J T Liu; H A Boushey
Journal:  Environ Res       Date:  1995-08       Impact factor: 6.498

5.  Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids.

Authors:  S E Wenzel; S J Szefler; D Y Leung; S I Sloan; M D Rex; R J Martin
Journal:  Am J Respir Crit Care Med       Date:  1997-09       Impact factor: 21.405

6.  Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma.

Authors:  M Z Norzila; K Fakes; R L Henry; J Simpson; P G Gibson
Journal:  Am J Respir Crit Care Med       Date:  2000-03       Impact factor: 21.405

7.  Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids.

Authors:  Waldo Mattos; Sam Lim; Richard Russell; Anon Jatakanon; K Fan Chung; Peter J Barnes
Journal:  Chest       Date:  2002-11       Impact factor: 9.410

8.  Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8.

Authors:  P G Gibson; J L Simpson; N Saltos
Journal:  Chest       Date:  2001-05       Impact factor: 9.410

9.  The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma.

Authors: 
Journal:  Eur Respir J       Date:  2003-09       Impact factor: 16.671

10.  Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation.

Authors:  J V Fahy; K W Kim; J Liu; H A Boushey
Journal:  J Allergy Clin Immunol       Date:  1995-04       Impact factor: 10.793

View more
  21 in total

1.  B lymphocytes regulate airway granulocytic inflammation and cytokine production in a murine model of fungal allergic asthma.

Authors:  Sumit Ghosh; Scott A Hoselton; Scott V Asbach; Breanne N Steffan; Steve B Wanjara; Glenn P Dorsam; Jane M Schuh
Journal:  Cell Mol Immunol       Date:  2014-11-03       Impact factor: 11.530

Review 2.  Neutrophil extracellular traps: a walk on the wild side of exercise immunology.

Authors:  Thomas Beiter; Annunziata Fragasso; Dominik Hartl; Andreas M Nieß
Journal:  Sports Med       Date:  2015-05       Impact factor: 11.136

3.  The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functions.

Authors:  Stipo Jurcevic; Charles Humfrey; Mohib Uddin; Steve Warrington; Bengt Larsson; Christina Keen
Journal:  Br J Clin Pharmacol       Date:  2015-10-02       Impact factor: 4.335

4.  Aerosolized polymerized type I collagen reduces airway inflammation and remodelling in a guinea pig model of allergic asthma.

Authors:  Paola Moreno-Alvarez; Edgar Sánchez-Guerrero; Erasmo Martínez-Cordero; Rogelio Hernández-Pando; María G Campos; Lucely Cetina; Blanca Bazán-Perkins
Journal:  Lung       Date:  2009-12-09       Impact factor: 2.584

5.  Complex association patterns for inflammatory mediators in induced sputum from subjects with asthma.

Authors:  A T Hastie; C Steele; C W Dunaway; W C Moore; B M Rector; E Ampleford; H Li; L C Denlinger; N Jarjour; D A Meyers; E R Bleecker
Journal:  Clin Exp Allergy       Date:  2018-04-15       Impact factor: 5.018

6.  High mobility group box 1: a novel mediator of Th2-type response-induced airway inflammation of acute allergic asthma.

Authors:  Libing Ma; Jinrong Zeng; Biwen Mo; Changming Wang; Jianwei Huang; Yabing Sun; Yuanyuan Yu; Shaokun Liu
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

7.  Diesel exhaust particulates exacerbate asthma-like inflammation by increasing CXC chemokines.

Authors:  Jiyoun Kim; Sudha Natarajan; Louis J Vaickus; Jacqueline C Bouchard; Dominic Beal; William W Cruikshank; Daniel G Remick
Journal:  Am J Pathol       Date:  2011-10-01       Impact factor: 4.307

8.  Pathogen induced chemo-attractant hepoxilin A3 drives neutrophils, but not eosinophils across epithelial barriers.

Authors:  S A Kubala; S U Patil; W G Shreffler; B P Hurley
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-12-04       Impact factor: 3.072

9.  Expression of the high affinity IgE receptor by neutrophils of individuals with allergic asthma is both minimal and insensitive to regulation by serum IgE.

Authors:  Juanita Mora; Emily K Riggs; Jun Fu; Donald W MacGlashan; Susan A Fox; Byung Yu; Mary C Tobin; Larry L Thomas
Journal:  Clin Immunol       Date:  2009-04-08       Impact factor: 3.969

10.  Hepoxilin A(3) facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers.

Authors:  David L Tamang; Waheed Pirzai; Gregory P Priebe; David C Traficante; Gerald B Pier; John R Falck; Christophe Morisseau; Bruce D Hammock; Beth A McCormick; Karsten Gronert; Bryan P Hurley
Journal:  J Immunol       Date:  2012-10-08       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.